Hemas Holdings (COL:HHL.N0000) Interest Expense : රු-3,223 Mil (TTM As of Mar. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Hemas Holdings Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Hemas Holdings's interest expense for the three months ended in Mar. 2024 was රු -662 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was රු-3,223 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Hemas Holdings's Operating Income for the three months ended in Mar. 2024 was රු 2,332 Mil. Hemas Holdings's Interest Expense for the three months ended in Mar. 2024 was රු -662 Mil. Hemas Holdings's Interest Coverage for the quarter that ended in Mar. 2024 was 3.53. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Hemas Holdings Interest Expense Historical Data

The historical data trend for Hemas Holdings's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hemas Holdings Interest Expense Chart

Hemas Holdings Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Interest Expense

Get a 7-Day Free Trial

-981.66

-640.13

-633.40

-3,945.95

-3,223.05

Hemas Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-1,185.25	-970.53	-899.53	-691.45	-661.54

Hemas Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was රු-3,223 Mil.

Hemas Holdings (COL:HHL.N0000) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Hemas Holdings's Interest Expense for the three months ended in Mar. 2024 was රු-662 Mil. Its Operating Income for the three months ended in Mar. 2024 was රු2,332 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was රු5,408 Mil.

Hemas Holdings's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	2332.131	/	-661.542
	=	3.53

The higher the ratio, the stronger the company's financial strength is.

Hemas Holdings (COL:HHL.N0000) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » Hemas Holdings PLC (COL:HHL.N0000) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

No. 75, Braybrooke Place, Hemas House, Colombo, LKA, 02

Website

https://www.hemas.com

Hemas Holdings PLC holds investments in companies with diversified businesses in Sri Lanka. Its businesses include manufacturing, trading and distributing FMCG products, pharmaceutical products, healthcare products, provision of medical care, operating tourism business, hotel management, airlines, shipping business, IT solutions, among others. It has the following reportable segments: Consumer, Healthcare, Leisure, Travel & Aviation, Mobility, and Other segments. The healthcare segment which generates majority revenue distributes pharmaceuticals, surgical and diagnostics products, and owns and manages hospitals.

Hemas Holdings (COL:HHL.N0000) Headlines

No Headlines